Testing two surgery approaches for early left pancreatic cancer
Part of Cancer clinical trials.
This trial compares two ways of doing surgery in people with early, left-sided pancreatic cancer that can be removed. It may help find the approach with better outcomes while aiming to keep the operation safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with resectable left-sided pancreatic cancer and are planning surgery
- Your tumor measures 4 cm or smaller (on imaging)
- Your tumor is at least 1 cm away from the celiac trunk and has not spread into certain tissue behind the pancreas
- You have not had chemotherapy or radiation before surgery (neoadjuvant therapy)
- There is no spread to the liver or other distant organs, and the cancer is not coming back or in multiple spots
- You can follow the trial plan and agree in writing; you are not in another cancer trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two surgeries for pancreatic cancer: laparoscopic (keyhole) pancreaticoduodenectomy and open pancreaticoduodenectomy. It aims to see which approach leads to fewer complications during recovery.
This trial studies a new blood test that looks for cancer-specific immune cells after surgery for pancreatic cancer. It aims to see if the test can detect any remaining cancer cells earlier than standard methods, which could help guide further treatment decisions.
This trial compares two surgical strategies to help prevent return of cancer after surgery for pancreatic body and tail ductal adenocarcinoma. You may be eligible if your cancer looks removable before surgery and your overall health and lab tests are within allowed ranges.
This trial compares a modified surgical technique to the standard one for removing pancreatic tumors. It aims to see if the new method lowers the risk of a leak from the pancreas after surgery.
This trial compares two types of surgery to remove tumors that start near the pancreas but not in it. The goal is to see if a newer, less invasive method works as well as the standard approach, which may mean fewer cuts and a faster recovery.
This trial compares robot-assisted surgery with standard keyhole surgery to remove growths on the left side of the pancreas. It may help doctors determine which method is safer and more effective for non-cancerous or pre-cancerous conditions.
Hear when a new Left-sided Pancreatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.